Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
GILD

Market Cap: $178.44B

GI

Gilead Sciences, Inc.

GILD

NASDAQ (NASDAQ Global Select)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin79.59%

EBITDA Margin2.09%

EBIT Margin-4.68%

Pre-tax Margin-6.42%

Net Profit Margin-10.64%

Earnings Yield-1.81%

Valuation Multiples

Price / Book15.10

Price / Sales5.86

Price / Earnings-55.28

PEG0.37

Forward PEG0.02

EV / Sales6.62

EV / EBITDA316.83

EV / Operating Cash Flow14.87

EV / Free Cash Flow15.27

Price / Free Cash Flow13.52

Price / Operating Cash Flow13.18

Cash Flow & Capital

Free Cash Flow / Share$10.62

Operating Cash Flow / Share$10.9

Free Cash Flow Yield7.40%

Capex / Revenue1.16%

Capex / Operating Cash Flow2.60%

Capex / Depreciation0.26

Stock Compensation / Revenue1.51%

Dividend Payout Ratio-1.26%

Dividend Yield2.24%

Liquidity & Leverage

Current Ratio1.27

Quick Ratio1.09

Cash Ratio0.29

Debt / Assets0.53

Debt / Capital0.69

Debt / Equity2.22

Long-Term Debt / Capital0.67

Debt / Market Cap14.71%

Net Debt / EBITDA36.27

Solvency Ratio-0.03

Financial Leverage4.17

Efficiency & Working Capital

Asset Turnover0.62

Fixed Asset Turnover5.22

Inventory Turnover3.18

Receivables Turnover6.02

Payables Turnover9.22

Days Sales Outstanding60.58

Days Inventory Outstanding114.66

Days Payables Outstanding39.57

Operating Cycle175.24

Cash Conversion Cycle135.67

Working Capital Turnover5.04

Returns & Quality

Return on Equity-16.28%

Return on Assets-6.56%

Return on Invested Capital-3.66%

ROCE-3.89%

Return on Tangible Assets-11.99%

Operating Return on Assets-2.83%

Income Quality2.59

Tax Burden1.66

Interest Burden1.37

Balance Sheet & Intrinsic Metrics

Enterprise Value$201.51B

Invested Capital$31.11B

Working Capital$2.93B

Tangible Asset Value$-10.6B

Net Current Asset Value$-23.67B

Graham Number$0

Graham Net-Net-$23.87

Book Value / Share$9.45

Tangible Book Value / Share-$8.53

Cash / Share$2.56

Financial Health Scores

Piotroski Score5

Altman Z-Score3.50

Revenue$30.46B

EBIT$-1.43B

Market Cap$178.44B

Working Capital$2.93B

Retained Earnings$2.2B

Total Assets$49.36B

Total Liabilities$37.62B